person · Reporting owner

Mohan Jitendra

Disclosed activity across 1 company

Tapewire entity: 21501
SEC CIK: 0001998053

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Astera Labs, Inc.ALAB · Entity 1853	Director · Chief Executive Officer	August 17, 2026	August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Astera Labs, Inc.

Report date August 17, 2026 · Filed August 19, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,266,665	Ending reported balance After 2026-08-17 transaction · row 18 18 source rows · reconciled sequence Row 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,356,717 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,355,668 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,353,684 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,352,627 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,349,127 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,346,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,329,229 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,325,516 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,320,067 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,318,457 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,315,841 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,309,357 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,301,365 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,290,927 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,287,981 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,286,199 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,279,273 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,266,665 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy Trust	699,999	Reported balance Holding disclosure · report date 2026-08-17 · row 19 Holding and transaction disclosures are not merged. 1 source row Row 19 · Balance 699,999 F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy Living Trust	3,789,232	Reported balance Holding disclosure · report date 2026-08-17 · row 20 Holding and transaction disclosures are not merged. 1 source row Row 20 · Balance 3,789,232 F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2021 Trust 1	700,000	Reported balance Holding disclosure · report date 2026-08-17 · row 21 Holding and transaction disclosures are not merged. 1 source row Row 21 · Balance 700,000 F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2021 Trust 2	700,000	Reported balance Holding disclosure · report date 2026-08-17 · row 22 Holding and transaction disclosures are not merged. 1 source row Row 22 · Balance 700,000 F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2022 Trust 1	450,001	Reported balance Holding disclosure · report date 2026-08-17 · row 23 Holding and transaction disclosures are not merged. 1 source row Row 23 · Balance 450,001 F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy 2022 Trust 2	450,001	Reported balance Holding disclosure · report date 2026-08-17 · row 24 Holding and transaction disclosures are not merged. 1 source row Row 24 · Balance 450,001 F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,752	$94.54	$1,678,304.26	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 771,003 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
June 17, 2025 Filed Jun 19, 2025 01:15 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	17,752	$94.54	$1,678,304.26	Disclosure SEC source: 0001736297-25-000065 · wk-form4_1750295709.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,351,010 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 15,279 shares sold at prices ranging from $96.7800 to $95.7950, 21,998 shares sold at prices ranging from $95.7750 to $94.7800, 44,589 shares sold at prices ranging from $94.7700 to $93.7800, and 24,644 shares sold at prices ranging from $93.7700 to $93.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,366	$100.00	$236,600.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 538,759 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,366	$100.00	$236,600.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 538,759 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,366	$100.00	$236,600.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 788,759 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,366	$100.00	$236,600.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 788,759 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,370	$100.00	$237,000.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 788,755 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,366	$100.00	$236,600.71	Disclosure SEC source: 0001628280-25-028840 · wk-form4_1748896570.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,368,762 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 14,200 shares sold at prices ranging from $100.0000 to $100.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 541,125 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 541,125 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 791,125 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 791,125 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 791,125 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 19, 2025 Filed May 21, 2025 22:43 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	21,375	$90.02	$1,924,166.81	Disclosure SEC source: 0001736297-25-000044 · wk-form4_1747867402.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,371,128 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,420 shares sold at prices ranging from $87.2900 to $88.2800, 4,870 shares sold at prices ranging from $88.3600 to $89.3500, 80,708 shares sold at prices ranging from $89.3800 to $90.3700 and 39,252 shares sold at prices ranging from $90.3800 to $90.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 16, 2025 Filed May 21, 2025 01:14 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	39,898	$90.33	$3,604,165.88	Disclosure SEC source: 0001736297-25-000042 · wk-form4_1747790085.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,262,318 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.2400 to $90.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 16, 2025 Filed May 21, 2025 01:14 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	42,589	$90.67	$3,861,672.40	Disclosure SEC source: 0001736297-25-000042 · wk-form4_1747790085.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,302,216 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.4250 to $91.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 16, 2025 Filed May 21, 2025 01:14 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,850	$92.15	$815,569.98	Disclosure SEC source: 0001736297-25-000042 · wk-form4_1747790085.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,344,805 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.7300 to $92.5550, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 812,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 562,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 562,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 812,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 812,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 14, 2025 Filed May 16, 2025 22:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$90.90	$1,136,290.00	Disclosure SEC source: 0001736297-25-000035 · wk-form4_1747432905.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,392,503 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 36,118 shares sold at prices ranging from $90.0000 to $90.9900 and 38,882 shares sold at prices ranging from $91.0000 to $91.8200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 825,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 575,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 575,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 825,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 825,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
May 08, 2025 Filed May 12, 2025 21:28 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.05	$888,126.25	Disclosure SEC source: 0001736297-25-000032 · wk-form4_1747085291.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,405,003 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 34,568 shares sold at prices ranging from $70.0050 to $70.9900, 35,932 shares sold at prices ranging from $71.0450 to $71.7050, 3,300 shares sold at prices ranging from $72.2600 to $73.1500, and 1,200 shares sold at prices ranging from $73.2650 to $73.3900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 837,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 587,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 587,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 837,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 837,500 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:10 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	12,500	$71.37	$892,110.00	Disclosure SEC source: 0001736297-25-000022 · wk-form4_1741209001.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,417,503 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 30,900 shares sold at prices ranging from $70.0000 to $70.9800, 20,180 shares sold at prices ranging from $71.0100 to $72.0000, 20,420 shares sold at prices ranging from $72.0100 to $72.8900, 1,698 shares sold at prices ranging from $73.1800 to $74.1500, and 1,802 shares sold at prices ranging from $74.2000 to $74.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	527	$92.35	$48,667.45	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,353,655 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.3450 to $92.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,051	$91.86	$1,198,894.88	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,354,182 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.3100 to $92.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	31,152	$90.89	$2,831,495.62	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,367,233 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.3050 to $91.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	151,238	$89.72	$13,568,665.02	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,398,385 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.3050 to $90.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	141,370	$88.92	$12,571,214.15	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,549,623 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.3100 to $89.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 19, 2025 Filed Feb 21, 2025 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	13,342	$87.83	$1,171,769.16	Disclosure SEC source: 0001736297-25-000015 · wk-form4_1740177409.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,690,993 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.3100 to $88.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 29, 2024 Filed Dec 3, 2024 21:13 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	12,600	$0.00	$0.00	Disclosure SEC source: 0001736297-24-000059 · wk-form4_1733260373.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 4,430,003 F1 · kind: Represents a bona fide gift of shares to a charitable entity. F2 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,892	$110.12	$3,181,647.71	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 850,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,895	$110.12	$3,181,978.08	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 600,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,895	$110.12	$3,181,978.08	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 600,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,895	$110.12	$3,181,978.08	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 850,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,894	$110.12	$3,181,867.96	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 850,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 25, 2024 Filed Nov 27, 2024 22:26 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,895	$110.12	$3,181,978.08	Disclosure SEC source: 0001736297-24-000057 · wk-form4_1732746368.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,442,603 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 21, 2024 Filed Nov 25, 2024 23:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,509	$103.53	$2,951,670.76	Disclosure SEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 878,892 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
November 21, 2024 Filed Nov 25, 2024 23:01 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	28,511	$103.53	$2,951,877.83	Disclosure SEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 628,895 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.